NCT07157085Completed
AI Multitask Model for HCC Treatment
AI-Driven Multitask Model for Guiding Treatment Decision-Making in Hepatocellular Carcinoma
Source: ClinicalTrials.gov · Last updated 5 Sept 2025
Brief summary (registry, in English)
We will integrate multi-modal cardiac data via an AI multitask framework to develop and validate concurrent models for liver function, treatment prognosis, and microvascular invasion (MVI) prediction in hepatocellular carcinoma. The resulting tool will be prospectively deployed to guide personalized surgical, TACE, and systemic therapy decisions.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 7000 (actual)
- First submitted
- 28 Aug 2025
- Start date
- 1 Jan 2008
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07157085
What you commit to
- Study type: Observational
- Participants enrolled: 7000
- From 1 Jan 2008 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- HCC combined with other malignancies;
Other
- missing image data during perioperative period;
- lost to follow-up \> 12 months.
Who the study is looking for
- age 18-75 years;
- HCC diagnosed according to the European Association for the Study of the Liver/American Association for the Study of Liver Diseases criteria)
- Eastern Cooperative Oncology Group performance status \< 2;
- Child-Pugh class A or B liver function;
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.